EUVIMEDEUVIMED entdecken
Crossref

Discovery of Arene Ruthenium(II) Complexes as Potential VEGF Inhibitors for Glioblastoma Metastasis Suppression

Chanling Yuan, Chunguang Zhu, Qingshuang Lv, Jiahui Shi, Jiacheng Wang, Shiqi Gao, Jiayi Qian, Yanhua Chen, Qiong Wu, Wenjie Mei iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00797 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Chanling Yuan und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guangdong Province Engineering and Technology Centre for Molecular Probe and Biomedicine Imaging, Guangdong Pharmaceutical Univer…. Hauptthemen laut MEDLINE: Glioblastoma, Zebrafish, Antineoplastic Agents, Cell Proliferation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Guangdong Provincial Department of Science and Technology, China Postdoctoral Science Foundation, Department of Education of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Developing drugs for treating glioblastoma has been a significant challenge. Herein, a series of arene ruthenium(II) complexes have been synthesized and investigated as potential candidates to suppress the proliferation and metastasis of glioblastoma. It is found that para-substituent-modified molecules, especially 6, exhibit higher antitumor activity than ortho-substituents. Further studies show that 6 can trigger tumor cell autophagy by regulating the PI3K/AKT/mTOR pathway. Moreover, it is also found that 6 can induce DNA damage in glioblastoma cells through binding and stabilizing VEGF G-quadruplex DNA. Furthermore, it is confirmed that 6 can inhibit the proliferation and metastasis of U87-MG glioblastoma cell in situ xenograft in the zebrafish model. Hence, arene ruthenium(II) complexes can be developed as promising therapeutic agents for glioblastoma treatment in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaZebrafishAntineoplastic AgentsCell ProliferationRutheniumVascular Endothelial Growth Factor ACoordination ComplexesHumansAnimalsCell Line, TumorDrug DiscoveryAutophagyG-QuadruplexesStructure-Activity RelationshipDNA Damage

Substanzen

Antineoplastic AgentsRutheniumVascular Endothelial Growth Factor ACoordination Complexes

Autor:innen und Institutionen

  • School of Pharmacy, Guangdong Province Engineering and Technology Centre for Molecular Probe and Biomedicine Imaging, Guangdong Pharmaceutical University, Guangzhou 510006, China.
  • Institute of Biological and Medical Engineering, Guangdong Academy of Sciences, Guangzhou 530316, China.

ORCID-Profile: Wenjie Mei

Förderung

  • Guangdong Provincial Department of Science and Technology
  • China Postdoctoral Science Foundation
  • Department of Education of Guangdong Province
  • National Natural Science Foundation of China
  • Scientific Research Projects in Universities of Guangdong Province

Zitieren

APA

Yuan, C., Zhu, C., Lv, Q., Shi, J., Wang, J., Gao, S., Qian, J., Chen, Y., Wu, Q., & Mei, W. (2024). Discovery of Arene Ruthenium(II) Complexes as Potential VEGF Inhibitors for Glioblastoma Metastasis Suppression. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00797

Vancouver

Yuan C, Zhu C, Lv Q, Shi J, Wang J, Gao S, et al. Discovery of Arene Ruthenium(II) Complexes as Potential VEGF Inhibitors for Glioblastoma Metastasis Suppression. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00797

BibTeX
@article{Yuan2024,
  author = {Yuan, Chanling and Zhu, Chunguang and Lv, Qingshuang and Shi, Jiahui and Wang, Jiacheng and Gao, Shiqi and Qian, Jiayi and Chen, Yanhua and Wu, Qiong and Mei, Wenjie},
  title = {Discovery of Arene Ruthenium(II) Complexes as Potential VEGF Inhibitors for Glioblastoma Metastasis Suppression},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00797}
}
Kostenlos starten →